Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of XEN1101 as an Adjunctive Therapy in the Treatment of Primary Generalized Tonic-Clonic Seizures

              Author:Gil-Nagel, Antonio   Vossler, David   Ben-Menachem, Elinor   LaFrance, W.   Harden, Cynthia   Qian, Jenny   Beatch, Gregory   Kenney, Christopher   

              Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P11.012  

              Author Institution:Hospital Ruber Internacional, Madrid, Spain, Madrid, Spain  University of Washington, Seattle and UW Medicine/Valley Medical Center, Renton, WA, USA, Renton, WA  Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden  Rhode Island Hospital, Brown University, and VA Providence Health Care System, Providence, RI, USA, Providence, RI  Xenon Pharmaceuticals Inc., Burnaby BC, Canada, Burnaby, BC, Canada